Here are the key steps in my approach for a female patient referred for recurrent UTIs:
1. Take a detailed history regarding symptoms, number and timing of previous UTIs, results of urine cultures, potential complicating factors.
2. Perform a physical exam paying attention to the abdomen and genitourinary system.
3. Order urinalysis and urine culture to confirm current infection.
4. Consider further imaging like renal ultrasound if history suggests possibility of structural abnormalities.
5. Review medications for potential interactions.
6. Discuss lifestyle and hygiene modifications that may help reduce risk of recurrence.
7. Consider prophylactic antibiotics if recurrent infections are severe or frequent. The choice would
The surgical treatment of an injury or defect within the urethra's walls is known as urethroplasty. The three most frequent factors leading to urethral damage that needs to be repaired are trauma, iatrogenic injury, and infections. The gold standard treatment for urethral strictures is urethroplasty, which has a lower recurrence rate than dilatations and urethrotomies. Although recurrence rates are higher for this challenging treatment group, it is likely the only effective treatment option for chronic and severe strictures.
Urethroplasty is not regarded as a small procedure, taking three to eight hours on average in the operating room. Between 20% and 30% of urethroplasty patients may benefit from the ease of going under the knife for a shorter period of time and going home the same day. On average, hospital stays last two to three days. Seven to ten days may be needed for hospitalization for more complicated surgeries.
Fewer than ten percent of patients experience significant complications after urethroplasty, while complications, particularly recurrences, are more frequent in long and complex strictures.
The surgical treatment of an injury or defect within the urethra's walls is known as urethroplasty. The three most frequent factors leading to urethral damage that needs to be repaired are trauma, iatrogenic injury, and infections. The gold standard treatment for urethral strictures is urethroplasty, which has a lower recurrence rate than dilatations and urethrotomies. Although recurrence rates are higher for this challenging treatment group, it is likely the only effective treatment option for chronic and severe strictures.
Urethroplasty is not regarded as a small procedure, taking three to eight hours on average in the operating room. Between 20% and 30% of urethroplasty patients may benefit from the ease of going under the knife for a shorter period of time and going home the same day. On average, hospital stays last two to three days. Seven to ten days may be needed for hospitalization for more complicated surgeries.
Fewer than ten percent of patients experience significant complications after urethroplasty, while complications, particularly recurrences, are more frequent in long and complex strictures.
bladder pain syndrome is highly prevalent. it is a diagnosis of exclusion. the biggest hurdle in management is diagnosis. more often than not patients suffering with BPS move from pillar to post, from a clinician to another, often getting urethral dilatations, receiving NSAIDS and even antipsychotics (having been labelled as 'psychiatric' patient).
once diagnosis is made, treatment is multipronged and based on phenotype - the concept is called UPOINT. interstitial cystitis is a small but significant minority (moreover ulcerative type) of BPS.
Gabapentin, amitriptyline and pentosan polysulfate are cornerstone pharmacotherapeutic agents for IC/BPS
bladder pain syndrome is highly prevalent. it is a diagnosis of exclusion. the biggest hurdle in management is diagnosis. more often than not patients suffering with BPS move from pillar to post, from a clinician to another, often getting urethral dilatations, receiving NSAIDS and even antipsychotics (having been labelled as 'psychiatric' patient).
once diagnosis is made, treatment is multipronged and based on phenotype - the concept is called UPOINT. interstitial cystitis is a small but significant minority (moreover ulcerative type) of BPS.
Gabapentin, amitriptyline and pentosan polysulfate are cornerstone pharmacotherapeutic agents for IC/BPS
Amebiasis is an intestinal (bowel) illness caused by a microscopic (tiny) parasite called Entamoeba histolytica, which is spread through human feces (poop). Often there are no symptoms, but, sometimes it causes diarrhea (loose stool/poop), nausea (a feeling of sickness in the stomach), and weight loss.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
2. Outline
• Definition
• Bacteriology
• Cystitis & urethritis
• Recurrent UTI
• Pyelonephritis, EPN & XGP
• General principles of antibiotic and prophylaxis
• Mx of septicaemia
• TB urinary tract
• Prostatitis
• Epididymal orchitis
• Viral disease of Genital tract (condylomata, AIDS, Herpes)
• Schistosomiasis
• Radiation cystitis
• Chemical cystitis and mx
• Antibiotic prophylaxis in uro procedure
3. Definition
• Bacteriuria: Presence of bacteria in urine
• Pyuria: presence of WBC in urine
• Sterile Pyuria: Pyuria without bacteriuria
1. Incomplete antimicrobial treatment of UTI
2. Infections caused by Mycobacterium tuberculosis
and other fastidious bacteria, e.g. Chlamydia
trachomatis
3. Urolithiasis and foreign bodies
4. CIS
5. Interstitial cystitis
6. schistosomiasis
4. Definition
• Cystitis:
– Clinical syndrome of dysuria, frequency & urgency +/-
Bladder pain
• Acute pyelonephritis:
– Syndrome of Fever, Chills & rigor, flank pain ,
bacteriuria + pyuria
• Chronic pyelonephritis:
– Radiological diagnosis
– Scarred , shrunkened kidney (may or maynot result
from recurrence infection)
5. What is the definition of UTI?
• UTI – Inflammatory response of
urothelium to microorganism invasion,
commonly bacteria , associated with
pyuria and bacteriuria
• Opportunistic infection : infection caused
by non-pathogens (commensals) due to
weakened host defence mechanisms
6. Definition of UTI
• Isolated UTI:
– Occur at least 6m after the previous UTI
• Recurrent UTI : >=2 UTI in 6m / >=3 UTIs in 1yr
– Bacterial persistence: UTI by same organism
• Nidus (stone, bladder/urethral diverticulum, chronic
prostatitis, colo-vesical fistula)
– Reinfection: by different organisms each time
• Increased susceptibility to UTI, e.g. poor hygiene, sexual
intercourse, post menopause
• > 95% female recurrent UTI is reinfection
7. Definitions of UTI
• Unresolved infection: not response to txn
1. Bacterial resistence to antibiotic
2. Development of resistance in a previously
susceptible organism
3. Multiple organism
4. Rapid re-infection & overwhelming pathogens
5. Subtherapeutic level of antimicrobial
6. Non-compliance with treatment
8. Definition of UTI:
• Complicated UTI
– Structurally and functionally abnormal urinary tract
– Underlying disease prone to complicated UTI
1. Male gender , elderly
2. Pregnancy
3. Catheter or stent or instrumentation
4. immunocompromised, DM, hospital acquired infection
• uncomplicated UTI
– No structurally and functionally abnormal urinary
tract
– No underlying disease prone to acquire UTI
9. How does the urinary dipstick –How does the urinary dipstick –
(blood) work?(blood) work?
• Chromogen indicator : orthotolidine is a peroxidase substrate
• Haemoglobin has peroxidase activity
• Oxidation process take place
• Positive result : BLUE
• False positive (oxidasing agent):
1. Povidone iodine
2. Hypochlorite (bleach)
3. Menstrual blood
4. Dehydration, exercise and myoglobin
• False negative (reducing agent):
– Vitamin C
– Poorly mixed urine
• Dipstick positive but microscopy negative – dilute urine
10. How does the urinary dipstick –How does the urinary dipstick –
(WBC) work?(WBC) work?
• Neutrophils produce leucocyte esterase
• Catalyzes the hydrolysis of a indoxyl carbonic acid ester
to indoxyl
• Idoxyl oxidise the diazonium salt chromogen to produce
blue colour
• False positive : vaginal discharge or formalin
• False negative (reducing agent)
1. Vitamin C
2. Dehydration
3. Glycosuria, urobilinogen
4. Test is read too fast (< 2min) or too long (lysis of WBC)
• 30% of infection with negative leucocyte esterase ( =
70% sensitivity)
11. How does the urinary dipstick –How does the urinary dipstick –
(nitrites) work?(nitrites) work?
• Gram negative bacteria convert nitrates to nitrites (not usually in
urine)
• Nitrite react with the aromatic amine to form diazonium salt
• Which react with hydroxybenzoquinolone to form pink colour
(Griess reaction) – 4 hours processing
• High specificity but low sensitivity – means +ve UTI, negative
cannot rule out UTI
• When negative for both nitrites and leukocytes 90% of MSU will
be negative for significant bacteriuria
• When positive for both nitrites and leucocytes, 80% will have
positive cultures on MSU
– More specific but less sensitive to either test alone
• False positive – contamination
• False negative – gram positive bacteria, pseudomonas, ascorbic
acid, and dilute urine, urine in bladder < 4 hours (so only early
morning urine is reliable)
12. Why is urine pH important?
• Normal urinary pH: 5.5- 6.5
• pH> 7.5 possibility of stone
• Urea splitting organism produce urease: (PKS, PPS)
1. Proteus
2. Klebsiella
3. Staphylococcus
4. Pseudomonas
5. Providencia
6. Serratia
• Induce following reaction:
– Urea CO2 + NH3 (ammonia)
– NH3 raise pH
– Precipitation of magnesium ammonium phosphate to form
staghorn stone
14. What are the definitions of
significant bacteriuria?
• Kass first introduced quantitative microbiology in
diagnosis UTI
– Significant bacteriuria ≥ 105
cfu/mL of pure growth
– However, miss 1/3 symptomatic UTI with growth ≥ 103
cfu/mLof pure growth
• > 103
: uncomplicated cystitis in women
• > 104
: uncomplicated pyelonephrisitis in women,
catheter urine in women, men
• Asymptomatic bacteriuria should be treated in children,
pregnant female and immunocompromized patents, prior
to an invasive genitourinary procedure for which there is
a risk of mucosal bleeding, but not DM or elderly patient
(Canada’s study)
15. What is the implication of
bacteriuria?
• A single in/out uretheral catheterization may be
complicated by bacteriuria in 5% of cases
• Bacteriuria is almost universal when the catheter
is left in situ for longer than 3 days
• 10-20% of patients with pyelonephritis have
bacteriuria
• Bacteriuria without pyuria may be found
– bacterial contamination
– Colonization (asymptomatic bacteriuria)
• Absence of pyuria may cause doubt on the
diagnosis of UTI
16.
17. Risk factor for bacteriuria
1. Female
2. Low oestrogen state (menopause)
3. Pregnancy
4. Age
5. Institutional state in elderly
6. Indwelling catheters
7. Previous UTI
8. DM
9. Stone disease
10.GU malformation & voiding dysfunction (including
obstruction)
18. How would you instruct the pt for
MSU?
• Women:
– Spread the labia
– Wash and cleanse the periurethral area with moist gauze from back to
front
– Void first 100-150ml , collect next 10-15ml
• Men:
– Circumcised: no special preparation
– Uncircumcised:
• Retract foreskin , wash glans with soap and rinse with water
• Keep foreskin retracted: collect 10-15ml
• Handling of MSU:
– Culture with hours or refrigerated immediately & culture within 24hr
– Microscopy: 5-10ml urine centrifuge for 5min (2000rpm)
– Culture: 0.1ml urine of split-agar plate
• Blood agar gram +ve culture
• Eosinmethylene blue (EMB) gram –ve culture
• Estimate CFU after overnight incubation
19. What is the gram’s stain?
• Bacterial smear is stained with crystal violet for 1-
2min then pour off
• Then Gram’s iodine for 1-2min then pour off
• Decolorized by acetone
• Washed with water and counterstained with safranin
for 2 mins
• Gram +ve: cell wall that retain the crystal violet dye
– MRSA is a gram +ve coccus. It is present on the skin
of about 40% of people. Over 90% of isolates produce
the penicillin binding protein which makes the strain
resistant to penicillin base antibiotics
• G-ve – pink safranin
22. Why patient will have UTI?
• An interaction of susceptibility of host &
virulence of organism
• Pathogenicity: ability of an organsim to
cause disease
• Virulence: degree of pathogenicity
– Characteristics of uropathogens to colonised
and flourish within the host
23. Bacterial virulence factors?
• Directed against external agents (i.e
antimicrobial resistence)
– Inherited chromosomally (intrinsic resistance of
proteus to nitrofurnatoin)
• Enzyme inactivation: beta-lactamase which hydrolyses the
beta-lactam bone within penicillin gp of antibiotic
• Secrete by S. aureus , gonorrhoea & enterobacteria
– Acquired chromosomally (mutations)
• Alter the antibiotic target & receptor activity
– Acquire extra-chromosomally (plasmids)
24. Direct against host:
1. General: extracellular capsule prevent phagocytosis (E coli)
2. Toxin, e.g. haemolysin
3. Enzyme, e.g. urease
4. Antihumoral factors, e.g. IgA inactiviting protein by gonorrhoea and
Proteus
5. Adherence mechanism – afimbrial or fimbrial types (E.coli)
– Afimbrial adhesin – Dr adhesins (UTI in children and pregnancy)
– Fimbriase: 100 pili, 5nm diameter , 2um long
– Type P fimbriae (mannose resistant) have adhesions that bind to renal
urothelium and are associated with >90% of pyelonephritis
– Type P fimbriae are more virulent and more adhesive than type 1 fimbriae
– Type 1 fimbriae (mannose sensitive) binds to elements of bladder urothelium
and are associated with cystitis
– Type 1 fimbriae are also referred to as mannose sensitive. This means that
fimbriae have the ability to adhere to and agglutinate guinea pig erythrocytes.
Such an event is inhibited by mannose
– S pili – both bladder and kidney infection
6. Others
– Penetration of host by schistosoma apine
– Intrinsic resistance of Proteus to nitrofurantoin
25. What are normal host defence
mechanisms against UTI?
1. Normal commersal flora of vaginal introitus and periurethral
area
– Lactobacilli reduced uropathogens to colonise by lowering pH
as a result of converting glycogen to lactic acid (lower pH)
2. Vaginal oestrogen and IgA
3. Normal antegrade flow of urine
4. Characteristic of urine (high osmolality, low pH, Urea , etc)
5. Mechnical integrity of mucous membrane
6. Normal exfoliation of urothelial cells
7. Tamm-horsfall protein by ascending limb of loop of Henle –
bind type 1 pili & prevent attachment
8. GAG (Glycosiaminoglycan) layer
26. Route of infection
• Ascending infection (majority)
– Bacteria colonize perineum, vagina & distal urethra
– Ascend to bladder (cystitis)
– Ascend to kidney (pyelonephritis), encourage by
reflux
• Hematogenous (uncommon):
– Staph aureus, candida, fungaemia & TB
• Via lymphatics:
– Inflammatory bowel disease
– Retroperitoneal abscess
30. Anbitiotic Formulary
• TMP-SMX—inhibits dihydrofolic acid reductase
– Enterococcus and Pseudomonas are resistant
• Nitrofurantoin—mechanism unknown
– Pseudomonas and Proteus resistant, not useful in upper tract infections,
development of resistance very low
• Cephalosporins—1st
to 3rd
generation increases Gram negative and
anaerobic coverage
• Aminopenicillins—effective enterococcus, 30% resistance
development in common uropathogen isolates.
• Aminoglycoside—combined with ampicillin 1st
line therapy for
urosepsis, nephrotoxic
• Flouroquinolone—DNA gyrase inhibitor, enterococcus resistant,
damages cartilage in animal studies
32. Uncomplicated Cystitis
• Absence of physiologic or anatomic
abnormalities & no recent urologic surgery
• 30% of women between age 20-40 have had a
UTI
– 80% E. coli
– 15% S. Saprophyticus
• Rarely occurs in men
– Uncircumcised
– HIV
33. Uncomplicated Cystitis
• Microscopic analysis
is more sensitive than
dip-stick testing
– Bacteriuria
– Pyuria
– Hematuria
Symptoms:
– Dysuria, frequency,
urgency, small urine
volumes, suprapubic
pain
• Differential Diagnosis:
– Vaginitis
– Urethral infection /
urethritis
– STD
34. Uncomplicated Cystitis
• Pretherapy urine Cx
only for the following:
– Dx in doubt
– Symptoms longer than
7 days
– Older than age 65
– DM
– Pregnancy
– All males
• Treatment (3-days):
– TMP-SMX
– TMP alone
– Nitrofurantoin
– Fluoroquinolones (use
for patients with allergy to
less costly drugs or with
high risk of infection with
resistant organism)
– Amoxicillin-
Clavulanate during
pregnancy
35. Urethritis
• Inflammation of urethra
• Men: STD with dysuria + urethral discharge
• Gonococcal urethritis (GU)
– gram-negative diplococcus Neisseria gonorrhoea (incubation 10 day)
– concomitant infection with Chlamydia trachomatis
– Investigation: urethral swab for C/ST
– Treatment:
• ceftriaxone 125 mg IM in a single dose
• cefixime 400 mg orally in a single dose
• plus treatment for chlamydia
• Quionolone is not recommended
• Non gonococcal urethritis (NGU)
– Chlamydia trachomatis (incubation 1–5 weeks)
– Azithromycin, 1 g as a single oral dose
– Doxycycline, 100 mg orally twice a day for 7 days
– Transmission to females results in increased risk of pelvic inflammatory
disease, abdominal pain, ectopic pregnancy, infertility, and perinatal
infection
36. • Gonococci located intracellularly as Gram-
negative diplococci
• Ciprofloxacin (gonococci) and doxycycline
(chlamydial) for 2 weeks if young
epididymoorchitis
• Fluoroquinolones are contraindicated in
adolescents (< 18 years) and pregnant women
38. Female refer for recurrent UTI ,
what is your approach?
• History:
– Age
– Isolated or recurrent UTI?
– Trace all previous MSU result
– Re-infection or persistence?
– Number of confirmed UTI in
one year
– Cystitis or pyelonephritis?
– Complicated or uncomplicated
infection?
– Hematuria (CIS)
• PMH:
– Marital and obs hx
– OCP
– STD
– DM
– TB
– Stone
– Constipation
– Neurological illness
– Previous UTI in childhood
• Family hx of UTI
– ABO bld gp Ag non-secretors
– Lewis non-secretor
– P bld gp secretors
39. PE
• Abd:
– Palpable kidney
– Palpable bladder
– Loin pain
• Vaginal examine:
– State of oestrogenisation
– Genital prolapse
– Urethral diverticulum
• Focused neurological examination
43. Why do women increase risk of recurrent
infection?
Susceptibility to infections
1. Increased number of receptors sites for
uropathogen
2. Shorter urethra
3. Close proximity to anus
4. Asymptomatic bacteriuria in pregnant women
5. Large PVR in older women
6. Genital prolapse
7. P blood group secretor / ABO blood group non-
secretor / Lewis non-secretor
8. HLA-A3 phenotype
44. What are the risk factors ofWhat are the risk factors of
recurrent UTI?recurrent UTI?
1. Reduce antegrade flow of urine (low fluid intake, BOO, neurogenic bladder)
2. Sexual intercourse
3. Use of spermicides
4. Urinary and fecal incontinence
5. Atrophic vaginitis
• Raz (NEJM 1993) published a small randomized trial of 93 post menopausal female
with recurrent urinary tract infections and reported a significant reduction in the
frequency of UTI’s in ladies treated with topical estriol
6. History of UTI
7. Immumocompromised, e.g. DM / HIV
45. Mx of recurrent UTI : general
measure
Aim: control symptom & reduce frequency of infection
• High fluid intake
• Void before and after sexual intercourse (vigorous
activity may “milk” the bacteria to the bladder)
• Avoid using detergents in her bath
• Avoid using spermicidal contraceptive
• Apply lactobacilli to vagina to keep her urine acidic
• Apply oestrogen to atrophic vagina to restore normal
vaginal environment and recolonisation with lactobacilli
• Cranberry juice (proanthocyanidin) – block bacterial
adherence to urothelium, 20% reduction risk of
infection
46. Treatment strategies
• < 3 UTI / year: patient initiated therpay
• > 3 UTI/ year: prophylaxis for 6/12
• Post-coital single dose therapy
47. Mx: Antibiotic
3 regimens available:
• Low dose long-term continuous antibiotics:
– Eliminate introitoal and enteric reservoir, does not cause resistant
– Trimethoprim (100mg) , cephalexin (250mg) ,nitrofurantoin(50mg) QD
– Break thru infection txn with course of A/B, then restart prophylaxis
– 6-12 months, 95% reduction of recurrence, but 60% reinfected after
stopping the antibiotics
• Postcoital antimicrobial prophylaxis
– Ciprofloxacin 125 mg once daily
– Nitrofurantoin 50 mg once daily – lower systemic absorption and less
microbial resistance, but avoided in pyelonephritis as tissue level in
kidney is low
– Avoid amoxicillin and cephalosporin which change fecal flora
• Intermittency self-start therapy:
– Recurrent uncomplicated cystitis
– 3-day course regimen of an antimicrobial with MSU beforehand
– If failed > send MSU for proper culture
– 1 week course if symptom persist or for men
48. • Trimethoprim:
– Eradicate gram –ve aerobic from gut and vaginal fluid (eradicate
source)
– Batericidal concentration in urine
– Adverse: GI disturbance, mylotoxicity, erythema multiforme,
TEN, photosensitivity
– Cautions in renal impairment
• Nitrofurantonin:
– No effect on gut flora
– High concentration in urine elimination of bacteria
– Would not induce bacterial resistance
– Adverse: Pulmonary fibrosis , peripheral neruopathy,
agranulocytosis , liver damage
• Cefalexin:
– Would not induce resistance
– Adverse: GI upset , allergic rxn
• Fluoroguinolones :
– Short course eradicate enterobacteria from faecal & vaginal flora
– Adverse reaction: tendon rupture in 48 hour (esp with
concomittent use of steriod) , GI , Steven-Johnson syndrome
49. Mx if bacterial persistent
• Identify potential cause:
– KUB (stone)
– Renal USG (hydronephrosis, stone)
– FR + RU
– IVU or CTU
– FC (bladder stone, Ca bladder, urethral or
BNS , fistula)
• Txn: treat underlying cause
51. Acute pyelonephritis
• Inflammation of the kidney and renal pelvis
• Presentation:
– Fever, chills rigor
– Flank pain and tenderness
– Lower UTI symptom
– Unilateral or bilateral
• Ddx: cholecystitis, pancreatitis, diverticulitis, apendicitis
• Risk factor:
– Female
– VUR, Urinary tract obstruction or Neuopathetic bladder
– DM, immunocompromised state
– Congenital malformation
– Pregnancy
– Catheter and instrumentation
52. Acute pyelonephritis
• Pathology:
– Patchy infiltration of neutrophil & bacteria in
parenchyma
– Inflammatory band extending to cortex
– Small cortical abscess (80%)
• Organism: E.coli , enterococci, klebsiella ,
proteus, pseudomonas
• Investigation:
– Bld
– KUB
– MSU
– USG if derange RFT
53. Radiologic Findings
• Generalized renal enlargement
– Overall length of 15cm
– 1.5cm greater length on the the affected side
• Focal renal enlargement
– Renal mass
• Cortical striations during the nephrogram
phase of the urogram (perinephric
stranding)
• Dilatation of ureter/pelvis
54.
55. Treatment
• Not systemically unwell : oral
cirprofloxacin 500mg BD for 10 days
• Systemically unwell:
– IVF
– IV antibiotic (quinolone +/- gentamicin)
• Change to oral antibiotic after afebrile
• Complete antitbiotic for 14 days intotal
56. Is it necessary to perform
upper tract imaging?
• If the patients remain febrile after 72 h of
treatment
• Evaluation of the upper urinary tract with
ultrasound should be performed to rule out
abscess, urinary obstruction
• CTU: pyonephrosis, perinephric abscess ,
emphysematous pyelonephritis, Stone
• Chronic pyelonephritis – scarred shrunken
kidney
57. What is the antibiotic of
choice?
• Augmentin is not recommended as a drug of first
choice for empirical oral therapy of acute
pyelonephritis. It is recommended when
susceptibility testing shows a susceptible Gram-
positive organism
• In communities with high rates of fluoroquinolone-
resistant and extended-spectrum β-lactamase
(ESBL)-producing E. coli, initial empirical therapy
with an aminoglycoside or carbapenem has to be
considered until susceptibility testing demonstrates
that oral drugs can also be used
58. Chronic Pyelonephritis
• Dx: Radiologic, Pathologic
– Radiographically scarred & shrunken
• Often no history of UTI
– Bacterial antigens detectable in renal tissue
• Unpredictable association between
infection and renal scarring
• Early antimicrobial treatment decreases
scarring
59. Chronic Pyelonephritis
• Associated with reflux nephropathy
– Scarring associated with reflux of infected urine
– No scarring with reflux of sterile urine
• 55 Adults with reflux nephropathy
– UTI diagnostic event in 80%
– 20% with enuresis
– 50% with elevated serum creatinine
– 38% had hypertension
– 35% had proteinuria
62. Renal Abscess - Etiology
• Majority are secondary to ascending
gram-negative infection
– Associated tubular obstruction (due to prior
infection or calculi)
• Skin carbuncles or IVDU may lead to
gram-positive abscess formation
• Complicated UTI with associated stasis
due to calculi or neurogenic bladder.
63. Renal Abscess – Clinical Sx /
Labs
• Symptom:
– Fever , chill , pain
– weight loss, malaise
• Lab: Marked leukocytosis
• UA may be normal, unless there is
communication between abscess and
collecting system
64. Renal Abscess – Radiologic
findings
• CT of early abscess:
– Renal enlargement
• CT of late abscess:
– Fibrotic wall
– Obliteration of
adjacent tissue planes
– Ring-enhancing
• U/S shows
hypoechoic mass
65. Renal Abscess - Treatment
< 3 cm: IV ABx & observation
- Serial exam with U/S or CT until resolution
3-5 cm: Percutaneously drain
>5 cm: Surgical I&D
67. Pyonephrosis - Diagnosis
• F/C/Pain
• Lack of bacteriuria indicates complete
ureteral obstruction
• Urographic findings – obstruction
• Infected hydronephrosis always shows
good ultrasonic transmission;
pyonephrosis shows persistent echoes or
a fluid-debris level
68. Pyonephrosis - Treatment
• Antimicrobial drugs
• Drainage of the infected pelvis (ureteral
cath or perc drain)
• Identify & treat source of infection after
patient becomes hemodynamically stable
69. Perinephric Abscess
• Located within Gerota’s fascia
• 56% mortality rate
– Delay in Dx (misdiagnosed as acute pyelo)
• Due to hematogenous seeding or from
renal extension of ascending UTI
– Use of antimicrobial therapy has decreased
the chance of hematogenous seeding from
wound and skin infections.
70. Perinephric Abscess -
Diagnosis
• No pathognomonic abnormalities on any
radiologic examination.
• Decreased renal mobility is the most
specific finding – (Insp/Expir films).
• U/S or CT Scan – Dx &/or Treat
• Treatment: Drainage (surgical vs. perc)
71. Perinephric Abscess vs. Acute Pyelo
• >5 days of symptoms
prior to hospitalization
• Fevers persist beyond
4 days
• <5 days of symptoms
prior to hospitalization
• No fevers beyond 4
days after appropriate
antibiotics started
74. What is Systemic inflammatory
response syndrome (SIRS) ?
• Response to infection (sepsis) or non-infection (burn, pancreatitis)
• 2 of the criteria require
75. What is the pathogenesis of
sepsis?
• Endotoxin release by G-ve bacteria
• Trigger release of mediators, like cytokine,
activation of kinin system, complement
system and fibrinolytic system
• Activation of white cell and macrophages
• Widespread microvascular injury, tissue
ischemia & clinical manifestation
76. Pt is very unwell , what to do?
• ICU
• Consideration of vasopressor, inotropes,
steriod
• Radiological investigation to identified
source and complication
82. EPN causes and pathogenesis
• Acute necrotizing infection of the renal parenchyma and
its surrounding tissues by gas forming organism
• Presence of gas in the renal parenchyma, collecting
system or perinephric tissue
• Most common: Escherichia coli in 70% and Klebsiella
• Others:
– Proteus mirabilis, Group D Steptococcus and CNS
– Anaerobic and rare: Clostridium septicum, Candida albicans,
Cryptococcus neoformans and Pneumocystis jiroveci
• Bacteriaemia: found in 50% EPN, same species as
urine/pus
• Severe, acute pyelo that fails to improve during the initial
3 days of treatment
83. EPN pathogenesis
• Female: Male = 6:1
• Factors
– High glucose level (DM)
– Gas-forming microbes
– Impaired vascular blood supply
– Reduced host immunity
– Urinary tract obstruction (stone)
• Mechanism
– G-ve facultative anaerobes e.g. E coli produce gas via
fermentation of glucose high levels of nitrogen, oxygen, CO2
and H2 accumulating at inflammatory site gas may extended
the inflammatory site to subcapsular, perinephric and pararenal
spaces
84. EPN histopathology
• Abscess formation
• Foci of micro and
macro-infarction
• Vascular thrombosis
• Numerous gas-filled
spaces
• Area of necrosis
surrounded by acute
and chronic
inflammatory cells
implying septic infarction
86. EPN diagnosis
• Radiological Dx
– Gold standard: CT
• CT: more sensitive and
define extent of EPN by
identifying features of
parenchymal
destruction
• USG accuracy 69%,
KUB 65%
– KUB: abnormal gas
shadow in renal bed
87. EPN classification
• Base on CT feature
• Wan: used in 2 meta-analysis, prognostic value,
type 1 > 60% mortality, type2 > 20% mortality
• Huang and Tseng: for Mx
• One classification proposed by Wan et al
– Type I : parenchymal destruction with either an
absence of fluid collection or presence of streaky or
mottled gas (mortality 60%)
– Type II : renal or perinephric fluid collection with
bubbly or located gas or gas in the collecting system
(mortality 20%)
88.
89. EPN prognostic factors
• Falagas et al J Uro
2007
• Poor PF:
1. SBP <90
2. Impaired consciousness
3. Increase serum Cr
4. Thrombocytopenia
5. Bil EPN
6. Medical Mx with Abx
alone
7. Wan’s Type I (air only, no
fluid)
• Factors NOT increased
mortality
– DM
– Stone
– E. coli
– K. pneumaiae
– Age >50
– Female
– Hx of UTI
– Alcoholism
90. EPN management
• High index of suspicion in pt fail medical treatment
for acute pyelonephritis
• Active resuscitation
• Medical Mx (MM)
– O2, IVF, Acid base balance, Abx, good glycaemic
control
– Keep SBP >100 with IVF +/- inotropes
– Empirical Abx: AG, b-lactamase inhibitor, CS,
quinolones, till c/st a/v
– Renal support if ARF
– ICU care if multiorgan support need
91. EPN Management
• Percutaneous drainage PCD + MM
– 1st
shown in Hudson et al. J Urol 1986
– Meta-analysis (Somani BK et al. J Urol 2008):
• PCD + MM as most successful Mx (30-100%) with lowest
mortality 13.5%, subsequent nephrectomy mortality 6.6%
– Significant reduction in mortality (nephrectomy mortality 40-50%)
– Preserve function of affected kidney in ~70% cases
– For pt with localized areas of gas + functioning renal tissue
– Multiple catheters for loculated/multiple abscess
– Tube can be flushed with Abx solutions
92. EPN: PCD + MM
• Huang and Tseng classification
– Class 1 (gas in collecting system only): PCD + MM
– Class 2 (parenchymal gas only): PCD +MM
– Class 3 (3A peripheric gas, 3B pararenal gas):
• Depend on risk factors:
– diabetes, thrombocytopenia, acute renal failure, altered
level of consciousness, shock
• 0-1 risk factor: PCD+MM survival rate 85%
• >=2 risk factors: failure 90% nephrectomy
– Class 4 (soliatory kidney/Bil EPN):
• PCD + MM
– If failed to respond: Nephrectomy + ICU + renal support
93. Huang and
Tseng
classification
Class 1 Pelvicalyceal gas only
Class 2 Parenchymal gas only
Class 3A Perinephric gas
Class 3B Pararenal gas
Class 4 Solitary kidney/Bil
EPN
Risk factors:
1.DM
2.PLT
3.ARF
4.GCS
5.Shock
96. • KUB and CT scan of a patient with vague
R flank pain and ballottable mass
• What is the diagnosis? (3)
• Under microscopy, what is a characteristic
feature in this condition? (2)
98. XanthogranulomatousXanthogranulomatous
PyelonephritisPyelonephritis
• Chronic renal infection that results in local or
diffuse (2 types) renal destruction.
• Almost all cases are unilateral
• A nonfunctioning, enlarged kidney associated with
obstructive uropathy secondary to nephrolithiasis
• Female in their 5th to 7th decade
• 75% have positive urine cultures and 90% have
positive tissue culture
• The commonest organisms isolated are Proteus or
E.coli
• 83% of patients have associated nephrolithiasis
• 50% such stones are of staghorn stones
99. Xanthogranulomatous PyelonephritisXanthogranulomatous Pyelonephritis
• Presentation: 70% flank pain, 70% fever/chills, 60% flank mass
• Histologically
– Accumulation of lipid-laden foamy macrophages (xanthoma
cells)
– Inflammatory process begins within the pelvis and calyces &
subsequently extends into and destroys renal parenchymal and
adjacent tissues.
– Can be confused with RCC even on frozen section
• Treatment :
– if malignancy suspected / kidney diffusely destroyed – open
nephrectomy
– very stuck and high risk of vessels and visceral injury
• Imaging triad (seen in 50-80%) :
– Unilateral renal enlargement
– no / poor function
– A large calculus in the renal pelvis
• Classic “Bear’s paw sign” on CT
101. How to diagnosis urinary TB?How to diagnosis urinary TB?
• Presentation:
– Previous TB exposure
– Loss of appetite
– Fever, night sweat
– Loin pain , hematuria and suprapubic pain
• Physical examination:
– Temp , LN
– Chest , abdomen , genital (bead like cord)
• Bld , EMU, CXR, KUB, USG + RU
102. • EMU – more concentrated as TB is secreted
intermittently
1. Ziehl-Neelsen stain to look for acid fast bacilli
1. Bacterial smear is stained with carbol fuchsin for 2 minutes,
then decolorised with HCL and ethanol which then restained
with crystal violet view under oil immersion
2. Acid-fast bacilli pink, non acid fast bacilli purple
3. Not suitable for gram stain as high lipid content of cell wall
2. Lowenstein-Jensen is an egg based solid culture medium
used to identify TB
3. Culture in a liquid medium takes 2-3 days whereas in a solid
medium takes 6-8 weeks
4. PCR to amplify the specific DNA by in-vitro enzymatic
replication
• Pathogensis – caseating granuloma (Langhan’s giant cells
surrounded by lymphocytes and fibroblast) fibrosis +
calcification autonephrectomy
• TB epididymis is likely from hematogenous spread as it is usually
isolated finding
103. How to diagnosis urinary TB?How to diagnosis urinary TB?
• Tuberculin: purified protein deverivative to prove TB status.
– Positive confirmed exposure to TB
– Negative exclude the diagnosis
• CXR: lung primary focus in 50% of cases with urogenital TB
• KUB shows calcification in 50% of cases
• CT or IVU is abnormal in 60-90% of cases
1. Small shrunken kidneys (autonephrectomy)
2. Infundibular stricture (pathognomonic)
3. Calyceal distortion + calcification
4. Papillary necorisis
5. Multiple ureteric stricture : commonly at lower third of ureter
6. Distortion of ureteric orifice – VUR (Golf-Hole app)
7. Contracted calcified bladder: Bullous edema , ulcearation and
hemorrhage (Thimble bladder)
8. Calcified vas (beaded), seminal vesicle or prostate
104. What is the treatment of TB?
• Isoniazid, rifampicin, ethambutol and
pyrazinamide for 2 months
• Isoniazid and rifampicin for 4 months
• Steroid for ureteric stricture that do not respond
to anti-TB drugs
• Cycloserine is used to inhibit the growth of BCG
sepsis within 24 hours
– But if will lower seizure threshoid
107. Acute bacterial prostatitis
• Infection of the prostate asso with LUT infection & generalized
sepsis
• Risk factor:
– UTI
– Acute epididymitis
– Catheter , post TURP
– Intraprostatic ductal relfux
– Phimosis
– Prostate stone
• Presentation:
– Systemic illness
– Preineal and SP pain
– Irritative LUTS
– AROU
– Prostate is exteremely tender
108. • Investigation:
– Bld + c/st
– MSU
• Txn:
– Antibiotic: Cirpo 500mg BD for 2-4 week
– Pain relief
– Catheter
– Prostate abscess: dx by TRUS or CT
– Drainage: percutaneous or TUR
109. Men present with recurrent UTI
• History:
– Associate LUTS
– Stone disease
– Diverticulum +/- fistula: pneumaturia, recurrent diarrhoea ,
rectal bleeding , fecaluria
– Chronic prostatitis : Dysuria, hematuria, Perineal/suprapubic
discomfort, Ejaculatory problems
• PE:
– Abd + kidney
– Suprapubic region
– External genitalia and prostate
• Investigation:
– MSU
– KUB
– USG
– FR + RU
– Specific test : Stemey + NIH-CPSI
110. UTI in men
• Men should receive, as minimum therapy,
a 7-day antibiotic regimen
• Minimum treatment duration of 2 weeks is
recommended, preferably with a
fluoroquinolone if prostatic involvement
• Prophylactic antibiotics reduce the risk of
bacteriuria and septicemia by 70% and
80% respectively after TURP
– Berry: Prophylactic antibiotics in TURP J Urol
2002
111. Prostatitis
• Definition: Infection or inflammation of prostate
• Chronic prostatitis:
– Clinical syndrome characterize by pain in perineum, pelvis, suprapubic
area or external genitalia
– Variable degree of voiding or ejaculatory disturbance
• Dx of exclusion : to rule out BPH , stricture, UTI
• Pathophysiology poorly understood:
1. Infection
2. Chemical irritation
3. Dysfunctional high-pressure voiding
4. Intraductal reflux
5. Altered immunity
– Proposed inflammatory process cause tissue edema &
intraprostatic pressure local hypoxia mediator
induced tissue damage altered neurotransmission in
sensory nerve pain and other symptom
112. What is the definition ofWhat is the definition of
prostatitis?prostatitis?
>10 WBC /HPF
Prostadynia – pain without positive culture or inflammatory component
114. Meares and Stamey
• Drink 400ml of water 30min before the test
• 4 sterile specimen container: VB1, VB2, EPS, VB3
• Expose glans penis and retract foreskin
• Cleanse the glans with soap
• 1st
10-15ml urine: VB1
• Pass next 100-200ml into toliet
• 2nd
10-15ml urine: VB2
• Patient bend forward & hold container marked EPS near
urethral meatus
• Massage prostate until few drops of prostatic secretion
are collected : EPS
• Void and collect the 10-15ml urine: VB3
115. Interpretation of Stamey test
• +ve VB1: Urethritis
• +ve VB2: Cystitis
• Chronic prostatitis
– II: +ve c/st in EPS & VB3
– IIIa: -ve c/st in EPS & VB3, +ve WBC
– IIIb : -ve c/st in EPS & VB3 , -ve WBC
• Modification of Stamey test:
– Pre & post-message test (PPMT) [Nickel]
– +ve post-message c/st chronic prostatitis
116. ProstatitisProstatitis
• NIH – CPSI (National Institutes of Health- Chronic Prostatitis
Sympotm Index)
– Measure the severity of chronic prostatitis
– 9 item questionnaire with 3 main domains (pain, urinary symptoms and
QOL)
– Pain (location, frequency , severity)
– Voiding (obstructive and irritative)
– QOL
– For assess need of treatment and monitor response
• MTOPS study suggests that prostatitis may be a predictor of BPH
progression
• Nickel and coworker report a 2% incidence of bladder CIS in
patients with clinical prostatitis and they therefore recommend urine
cytology when investigating men with suspected prostatitis
117. Management
• According to predominant symptom & QOL
• Discuss about benign nature of the condition
• Lock of evidence in favour of any treatment
• Goal should be symptom control rather than
eradication
• Conner stone:
– Antibiotic
– Anti-inflammatory
– Alpha-blockers
118. Chronic bacterial prostatitis RxChronic bacterial prostatitis Rx
• NSAID/Antibiotics at least 6 weeks - empirical treatment
suggested by European consensus group
• E Coli positive in prostate massage in asymptomatic patient
should be treated
• Quinolone and tetracycline – good penetration
• Moxifoxacin – good in G+ve
• Macrolide – good for chlamydia
• Tetracyclin for sub-clinical infection : Chlamydia & ureaplasma
• Nitrofurantoin and penicillin – poor penetration
• Add alpha blocker for 3m if no response by 6week
• Finasteride can cause a 50% improvement in the symptoms
of about 50% of patients with type 3 prostititis
• Muscle relaxant – diazepam or baclofen
• Tricyclic antidepressant: Amitriptyline
• Prostatic message if not responsive
– Expression of prostatic secretion, relief of pelvic muscle spasm,
physical disruption of protective biofilm and improve circulation
– Some symptomatic relief in ~1/4 to 1/3 patients
120. Scrotal pain and fever
• Ddx: Trauma , testicular torsion , epididymo-orchitis
• History
– Trauma
– < 35 yo STD: Chlamydial or gonococcal
– In old: UTI cause by E coli
– UTI : dysuria, frequency , urgency , SP pain
– Systemic illness
– Long term use of amiodarone (chemical epididymitis)
• P/E:
– Cannot diff from torsion
– Scrotal pain radiate to groin
– Erythema or scrotal skin
– Thickening of spermatic cord, reactive hydrocele
– Urethral discharge
– Elevation of scrotum relieved pain in epididymo-orchitis (Prehn’s
sign)
121. • Investigation:
– MSU
– Gram staining and C/st of urethral swab (Gram –ve intracellular
diplococci)
– Chlamydia: detect DNA by PCR on first void urine
– Basic blood test
• Treatment:
– Bed rest, scrotal suppor
– Analgesic
– Antibiotic: Cipro 500mg BD (cover gonococccal) + Doxycycline
100mg BD (cover Chlamydia) x 2 weeks
– If allergic to doxycycline azithromycin 1g x1
– If elderly likely E coli : Ciprofloxacin only
– Order USG if not resolved (abscess)
– FR + RU exclude underlying LUTS
• Complication:
– Abscess, infarction , chronic pain , infertility
• Mumps orchitis: 30% post-pubertal male, 3 day after
parotitis, 30% bilateral , result in testicular atrophy and
infertility
123. What is the biofilm?What is the biofilm?
• Complex aggregation of organisms on
solid substrate, protected by extracellular
mucopolysaccharide matrix in an aqueous
environment
• Or , structured community of micro-
organisms and their extracellular products
form on the surface of any biomaterial
125. Anatomic & Physiologic
Changes
• 1cm increase in renal length
• Smooth muscle atony of collecting system
– Progesterone & Uterus size
• Bladder displaced superior & anterior
• 30-50% increase in GFR
– Evaluate renal Fx if Cr >0.8 or BUN >13
– Normal to have proteinuria up to 300mg/24
hours
126. UTI
• Incidence of male UTI - 1%
• Incidence of female UTI – 5%
• Incidence of female UTI after
menopause – 20%
• High fluid intake/voiding every 4 hrs/
post-coital voiding/perineal hygiene
• -ve urine c/st to confirm eradication of
bacteria
127. Asymptomatic Bacteriauria
• All women should be screen at week16
• Definition:
– Asymptomatic + 10 5
(CFU) of a single pathogen / ml of urine
– But 102
CFU can also be counted as significant
• Asymptomatic bacteriuria in pregnancy – ~5%
• Risk of acute pyelonephritis: in 3rd
trimester
– 1-4% in all pregnant women
– 20-40% in untreated bacteriuria
• Treatment is necessary 1% if treated
128. • 3-day course of therapy
• Reculture urine 1-2 days after treatment
• Use parenteral agents to treat acute pyelonephritis
129. Antibiotics
Safe:
• Penicillin: OK
• Cephalosporin: OK
• Marcolide - Erythromycin (bacteriostatic): OK
Use with cautions:
• Nitrofurantoin: avoid in third trimester
– Fetal hemolytic anemia in G6PD deficiency mother
– hepatotoxicity, lung toxicity, inadequate urine concentration if GFR<60
• Aminoglycoside (bacteriostatic): CI in 2nd
and 3rd
trimesters
– can cross placental barrier: fetal ototoxicity & nephrotoxicity
– Used only for short periods for severe acute pyelonephritis threatening
materal-fetal prognosis
• Sulphonamide : contraindicated in third trimester
– Risk of neual tube defect in 1st
trimester due to anti-folate mechanism
– Risk of fetal anemia in G6PD def mother
• Triamethoprim : contraindicated in first trimester
130. Contraindicated:
• Fluoroquinolone (bacteriostatic):
contraindicated as toxicity to fetal cartilage and
joints, tendon damage
• Chloramphenicol: contraindicated in third
trimester as “grey-baby” syndrome
• Tetracycline (bacteriostatic): contraindicated
as hepatotoxicity, deposit in teeth and bone
• Recurrent UTI in pregnancy – cephalexin 125mg
daily
131.
132.
133.
134. Acute pyelonephritis
• USG findings: focal or diffuse hyperechogenicity,
thickening of renal pelvis and ureteral dilation
• Higher risk if asymptomatic bacteriuria / VUR
(correction of VUR cannot prevent UTI during
pregnandy) / history of renal scarring
• Complications associated with bacteria during
pregnancy
– Prematurity, low birth weight, prenatal mortality
– Maternal anemia
• Hospitalization and parental antibiotics
135. Pregnancy and VUR
• Higher chance of pyelonephritis if previous VUR or
history of renal scarring
• History of renal scarring
– Higher chance of HT (3.3 fold)
– Pre-eclampsia (7.6 fold)
– Obstetric intervention
• Higher chance of pre-eclampsia if bilateral scarring
or impaired creatinine level
• Despite previous reimplantation in childhood, still
higher risk of UTI, but not miscarrage
136. (Spontaneous renal rupture)
• No cause vs upper tract obstruction vs
tumour like AML
• Lumbar or abdominal pain / shock
• US : retroperitoneal hematoma
• JJ / PCN if obstruction
• Unstable hemodynamically: nephrectomy
139. How to use gentamicin?
• Bactericidal – inhibit ribosomal protein synthesis
• 3-7mg/Kg
• Check level after the 3rd dose
• <1mg/l give the same dose
• 1-2mg/l reduce the dose by 25% and check the level before
next dose
• 2mg/l omit one dose and check the level
• Bad with Frusemide (increase nehrotoxicity)
• Good for pseudomonas, enterococcus and staphylococcus
• Daily dose is usually used
• Can be used in patient with renal impairment with dose modification
• Ototoxicity cause more commonly vestibular damage than
deafness, 2/3 patients present as tinnitus
• Nephrotoxicity and impaired neuromuscular transmission
143. • Up to 25% of hospitalized patients undergo urinary catheterization.
• indwelling urinary catheters are a leading cause of nosocomial
infection and have been associated with both morbidity and
mortality.
• Up to 30% of catheterized patients can have genitourinary or
systemic symptoms related to catheter-associated UTI (CAUTI)
• Up to 4% may develop catheter-related bacteraemia
• Once the catheter has been removed some patients with
asymptomatic CAUTI continue to have bacteriuria or become
symptomatic
• To prevent or reduce this type of catheter-related morbidity, many
clinicians have a policy of administering a short course of
prophylactic antibiotics on catheter withdrawal for all or selected
groups of patients.
• Currently, the most appropriate agents for the empirical
management of CAUTIs seem to be co-amoxiclav, ciprofloxacin and
nitrofurantoin.
144. What is the recommendation of
catheter insertion and choice of
catheter?
149. Spinal cord injury patients
• 33% have bacteriuria
• UTI is the most common urologic complication &
the most common cause of fever in these
patients
• Risk factors:
– Bladder overdistention
– Elevated intravesical pressure
– VUR
– Impaired voiding
– Instrumentation
150. Clinical presentation &
Bacteriology
• Majority are asymptomatic
• Symptoms:
– Abdominal discomfort
– Urinary leakage
– Lethargy / Malaise
– Cloudy, malodorous urine
• E. coli isolated in only ~20%
• Enterococci, P. mirabilis, Pseudomonas
151. Management
• SP cath delay onset of bacteriuria, when
compared with indwelling urethral cath
• CIC allows for lowest risk of complications
• Urine culture prior to therapy
• Oral fluoroquinolone is 1st
line
152. Emphysematous cystitis
• Necklace appearance of gas beads in
bladder wall diagnostic of emphysematous
cystitis
• due to infection by gas forming organisms
(commonest E Coli) in an
immunocompromised patient (usually DM)
154. EC
• DDx:
– Instrumentation
– Fistula to hollow viscus
– Tissue infarct with necrosis
– Infection
• EC more common in
– Middle aged diabetic women
(M: F = 1:6)
• Predisposing factors
– DM (66%), Chronic UTI,
indwelling urethral catheter,
urinary stasis due to BOO,
neurogenic bladder
• Various s/s
– Asymptomatic, pneumaturia,
irritative voiding, acute
abdomen to severe sepsis
• Pathogens:
– E. coli (58%)
– Others: K. pneumoniae, P.
aeruginosa, Proteus mirabilis,
Candida albicans and C.
tropicalis, Aspergillus fumigatus,
Staphylococcus aureus, Group D
Streptococcus, Enterococcus
faecalis, Enterobacter aerogenes
and Clostridium perfringens and
Cl. welchii.
• Pathogenesis:
– like EPN,
– non-diabietic: urinary albumin as
substrate
155. EC
• Radiological Dx
– KUB: curvilinear area of
radiolucency delineating
the bladder wall with or
without intraluminal air
– CT: more sensitive, define
extent and severity,
differentiate vesicoenteric
fistula, intraabdominal
abscess, adjacent
neoplastic disease, EPN
• Histopathology
– Gross:
• Bladder wall thickening
with vesicles of varying
size
– Microscopic:
• multiple gas-filled
vesicles predominantly
within the bladder
mucosa, lined by
flattened fibrocytes and
multinucleated giant
cells
158. What is endotoxin?What is endotoxin?
• Lipopolysaccharide complex related to the outer
membrane of gram negative bacteria
• Gram negative sepsis
• Their lipid component is the toxic one (Lipid A)
and the polysaccharide element is the
immunogenic one (O-antigen)
• Endotoxins are heat stable to boiling point
160. What is papillary necrosis?What is papillary necrosis?
• Possible causes of papillary necrosis is
POSTCARD
• Pyelonephritis, Obstruction. Sickle cell,
Tuberculosis, Cirrhosis, Analgesic, Renal
vein thrombosis, Diabetes
164. ChancroidChancroid
• Presentation: painful nonindurated ulcer + tender unilateral
inguinal adenopathy
• Characteristic suppurative inguinal adenopathy
• Haemophilus ducreyi :
– fastidious (difficult to culture)
– short, fine, gram-negative streptobacilli
– FDA approved: PCR assays
• Treatment:
– Ciprofloxacin, (500 mg orally BD for 3 days)
– Erythromycin , (500 mg orally TID for 7 days)
– Azithromycin, (1 g as a single oral dose )
– Ceftriaxone, (250 mg as a single intramuscular dose )
– Tetracycline
165. Male 30 with painless ulcer over coronal
sulcus
166. Genital
• What is the diagnosis?
– Chancre, ulcer typically painless, indurated and with
raised border. Regional lymphadenopathy appear in
one week.
• What is the causative agent?
– Treponema pallidum (spirochetes), confirmed by dark
field examination
• What is the treatment?
– Penicillin – good prognosis if treated. If not treated >
neurosyphillis/dementia/gumma
168. Genital
• What is the diagnosis?
– Condyloma acuminatum
• What is the causative agent?
– Human papillomavirus types 6,11.
– Dysplastic types are caused by type 16, 18.
(premalignant)
• What is the treatment?
– Podophyllin, cautery after biopsy or surgical excision
or CO2 laser
171. Genital
• What is the diagnosis?
– Granuloma inguinale - Irregular painful ulcer with
purulent base. No inguinal lymphadenopathy, but
subcutaneous granulomatous process
– Dx: identification of “Donovan Body” on stained
smear
• What is the cause?
– Calymmatobacterium granulomatis
• What is the treatment?
– Tetracycline/ampicillin , septrin or erythromycin
172. 25 year old man with painful lesions
over penile skin
173. Genital
• What is the diagnosis?
– Genital herpes.
• What is the cause?
– Usually herpes simplex virus type 2 infection
• What is the treatment?
– Acyclovir, long term suppression may be
required if recurrence. Prevent transmission
with barrier contraception
175. Genital
• What is the diagnosis?
– Molluscum contagiosum – small papules, may
express cheesy-like material
• What are the diagnostic features on histology
exam?
– Molluscum bodies in cells (Basophilic inclusion filled
with the virus) in biopsy
• What is the cause?
– Viral infection by poxvirus, transmitted by sexual
contact
• What is the treatment?
– Self limited. Healed without scars. Podophyllin or
cauterisation
177. Schitosomiasis (Biharzia)
• Cause: trematode called Schitosoma
haematobium
• Endemic : Africa , Egypt, middle east
• Pathology :
– Fresh water snails release infective form of the
parasite (cercariae)
– Penetrate skin and migrate to live (schitosomules)
where they mature
– Adult form migrate to vesical vein
– Lay egg (containing miracidian larvae) leave body
by pentrating the bladder and enter urine
178. • 2 phase:
– Active: where adult worm laying eggs
– Inactive: when adult die and reaction to remaining egg
• Clinical presentation:
1. “Swimmer’s itch” : local inflammation by cercarial penetration
(24hr)
2. Katayama fever (acute schistosomiasis):
• Egg lying : induce fever, urticaria, LN, Hepatosplenomegaly
3. Acute inflammation phase: egg penetrate & excreted in urine :
hematuria, frequency and terminal dysuria
4. Chronic active phase:
• Low egg laying
• Nephritic syndrome by deposition of IG complex in glomeruli
5. Chronic inactive phase: no viable egg
• Symptom of obstructive uropathy
179. Diagnosis + MxDiagnosis + Mx
Diagnosis:
1. Midday urine: continue egg
2. Bladder and rectal biopsy : identify egg
3. Serology test: ELISA
4. Cystoscopy: identifies egg in trigone (Sandy Patches)
5. CT or IVU: calcified , contracted bladder with obstrucitve uropathy
6. USS: hydronephrosis and thicken bladder wall
Treatment is pharmacological with praziquental
• 20 mg/kg in 2 divided does 4-6 hours apart on the same day
• Single dose of praziquental may be effective
• Praziquental is effective against all species of schistosoma and all
stages of the disease. It will cure 85-100% of cases. When it fails to
cure the disease a second course of praziquental could be tried
• Complications - Bladder contracture, ureteric obstruction, squamous
cell ca bladder
180. These are the eggs of 3 species of Schistosoma
Which of the above species is related to bladder cancer?
(1)
In what form does this species infect human in water? (1)
A B C
181. • A : Schistosoma japonicum
• B : Schistosoma haematobium
• C : Schistosoma mansoni
• B (1)
• Cercariae (1)
– The flatworm cercaria is found in river water and will penetrate
unbroken human skin, typically through the web between toes,
to enter the peripheral systemic vein
– The eggs will penetrate through the bladder wall and will be
found in the urine
182. Urinary schistosomiasisUrinary schistosomiasis
• Urinary schistosomiasis is most commonly
caused by schistosoma hematobium. This
is endemic in Africa and middle east. It
produces the characteristic end spined
eggs but this is not the only species with
end spined eggs
• Schistosoma japonicum is endemic in the
far east
• Schistosoma Mansoni in Latin America
183. What is the diagnosis? (1)
What is the acute phase of this disease called? (2)
184. • Characteristic egg-shell calcification outlining urinary
bladder
• Dx : Schistosomiasis (1), DDX: TB
• Katayama fever (2)
– Coincides with egg laying
– Active phase is characterized by urinary symptoms such as
hematuria and terminal dysuria. Cystoscopically there may be
inflammatory polypoid lesions in the bladder and eggs in the
urine
– The chronic inactive phase,although asymptomatic, will slowly
progress into obstructive uropathy and may be complicated by
bladder cancer
186. Hydatid diseaseHydatid disease
• Also known as echinococcus, is a tapeworm parasite infection
• The intermediate host is the sheep and the final host is the dog.
• Kidneys can be affected in about 5% of cases
• The disease is bilateral in 6% of cases
• In the kidney the upper and lower poles of the kidneys are more
commonly affected (80%) than the midpole of the kidney
• The renal cysts are not symptomatic until late in the disease
• Common symptoms are flank pain (80%) and flank mass (40-75%)
• USG and CT scans show thick wall multiloculated cysts
• KUB shows calcifications in 30% of cases
• Bld: peripheral eosinophilia & +ve hydatid complement fixation test
• Medical: Albendazole
• The mainstay of treatment is surgical excision of he cysts with 1st
sterilized with formalin or alcohol
189. Angiokeratoma of Fordyce
• Vascular ectasias of dermal blood vessels
• Visible on the penis and scrotum of adult men
• 1- to 2-mm red or purple papules with associated
generalized scrotal redness
• Benign condition without systemic manifestations
• Rare cause of troublesome scrotal bleeding Can
be seen in patients with Fabry's disease : rare
glycogen storage deficiency
• Treatment :
– Usually unnecessary
– Success achieved using YAG, KTP/ argon laser
photocoagulation in select cases
190. Physical findings of a sexually inactive 20-yr-old male
Diagnosis ? (2)
Is it associated with HPV infection? (1)
191. • Pearly penile papules (PPP) (2)
• No relationship with HPV. Benign lesion
(1)
192. PPP
• White, dome-shaped, closely spaced small
papules at glans penis
• Arranged circumferentially at corona
• Histology : angiofibromas similar to lesion TS
• 14-48% of young adults (uncircumcised)
• NO association with HPV infection/ cervical CIN
• Mx: Reassurance
• Local destruction: CO2 laser, cryotherapy
193. These ulcers in a sexually-inactive 20-yr-old man
are painful and recurrent.
Diagnosis ? (3)
Q29
194. • Pictures showing multiple scrotal, perianal
ulcers as well as oral aphthous ulcers
• Behçet’s disease (3)
195. Behçet’s disease
• Classified as a form of vasculitis
• Initially found along Silk Road, now found everywhere in the world
• No gender difference in epidemiology, mean age of onset ~30yrs
• Clinical manifestation:
– Mucous membrane manifestation
• Oral aphthosis (nearly in every patient)
• Genital aphthosis (60-100% of patients) : Scrotal and vulval ulceration,
sometimes on shafts of penis
– Skin manifestation
• Skin aphthosis / pustulosis
• Pathergy phenomenon (skin hypersensitivity to trauma, considered a
diagnostic test)
– Ocular manifestation
• Anterior and posterior uveitis, retinal vasculitis
– Arthritis, Meningoencephalitis, Vascular involvement (DVT), gastrointestinal
aphthosis
• Diagnostic criteria: International Criteria for Behçet’s disease (ICBD)
• Genetic background: HLA-B51 may be associated
• Treatment: Colchicine 1mg daily is 1st
line
196. This is the result of a chronic infective process
Name three possible micro-organisms responsible. (3)
Name one vector of transmission of the above micro-
organisms (1)
Q30
197. • Picture showing penoscrotal elephantiasis
1. Wucheraria Bancrofti (1)
2. Brugia Malayi (1)
3. Onchocerca volvulus (1)
4. Vectors
• (W. bancrofit, B. malayi) Mosquito eg. Culex spp
• (O. volvulus) Black fly of Simulium spp
• Dx: Thick film , serology or biopsy
• Presentation:
– Funiculoepididymitits, orchititis
– Hydrocele
– Scroal and penile elephantitis
• Treatment:
– Medical: Diethylcarbamazine
– Surgerical excision of fibrotic & edematous tissue
198. This is an STD
What is the diagnosis? (1)
What is the causative organism? (1)
Name two other diseases this organism is
responsible for (0.5 each)
Q47
199. • Lymphogranuloma venereum (LGV) (1)
• Chlamydia trachomatis (serotype L1, L2,
L3) (1)
1. Trachoma (serotype A, B, Ba, C) (0.5)
2. Non-gonococcal urethritis (serotype D to K)
(0.5)
200. Lymphogranuloma VenereumLymphogranuloma Venereum
• STD caused by Chlamydia trachomatis types L1, L2 & L3
• Transient painless ulcer on the penis, anus or vulvovaginal area that
goes unnoticed painful unilateral suppurative inguinal adenopathy
and constitutional symptoms that occur 2-6wks after resolution of the
ulcer
• Groove sign: large inguinal and femoral LN separated by inguinal
ligament. Secondary LN lesions in lymphogranuloma venereum
• Mainly clinical diagnosis
• Culture positive <50% cases
• Can be diagnosed using antibody titre
• Tx: Doxycycline 100mg BD or erythromycin 500mg QID for three weeks
at least
201. Photo
• This elderly woman complained of severe
symptoms of cystitis of sudden onset.
202.
203. Q
• A. What abnormality is shown?
– herpes zoster (1/2)
• B. What are the typical cystoscopic
appearances?
– hemitrigonal vesicles (1/2)
204. Q. CT
• These are CT and ultrasound scans of a
74 year old man with urinary retention and
fever of 38.6
205. Q
• A. What is the diagnosis?
– prostatic abscess (1)
• B. How should his retention be managed?
– suprapubic catheterisation and drainage of
abscess (1)
206. Antibiotic prophylaxis in urology
• Brief course of antibiotic administer before
or at the start of an intervention
• To minimize the infectious complications
of the procedure
• Possible side effect & microbial resistance
patterns are potential risk
207. • Yes with high level of evidence:
– TURP (decrease bacteriuria & infectious complication)
– Prostate biopsy (reduce bacteriuria but no conclusive evidence
on reducing symptomatic UTI or other infectious complication)
• Yes with moderate to low evidence:
– Cystoscopy (not require in the absence of risk factor)
– Therapeutic URS
– Open /lap uro intervention (clean-contaminated & contaminated)
• Not required in:
– Urodynamic study (except with increase risk e.g neurogenic
bladder, transplant patient, immunocompromised , VUR)
– TURBT
– ESWL (in uncomplicated case & pre-op –ve c/st)
– URS (diagnostic)
– PCNL (when pre-op –ve c/st)
– Open /lap uro intervention (clear surgery)